SLC44A4

solute carrier family 44 member 4, the group of Solute carrier family 44

Basic information

Region (hg38): 6:31863192-31879046

Previous symbols: [ "C6orf29" ]

Links

ENSG00000204385NCBI:80736OMIM:606107HGNC:13941Uniprot:Q53GD3AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • autosomal dominant nonsyndromic hearing loss (Supportive), mode of inheritance: AD
  • hearing loss, autosomal dominant 72 (Limited), mode of inheritance: AD
  • nonsyndromic genetic hearing loss (Limited), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Deafness, autosomal dominant, 72ADGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingAudiologic/Otolaryngologic28013291

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the SLC44A4 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the SLC44A4 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
26
clinvar
7
clinvar
33
missense
76
clinvar
6
clinvar
12
clinvar
94
nonsense
0
start loss
1
clinvar
1
frameshift
1
clinvar
1
inframe indel
1
clinvar
2
clinvar
3
splice donor/acceptor (+/-2bp)
2
clinvar
2
clinvar
4
splice region
3
11
2
16
non coding
3
clinvar
23
clinvar
30
clinvar
56
Total 0 0 84 59 49

Variants in SLC44A4

This is a list of pathogenic ClinVar variants found in the SLC44A4 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
6-31863656-G-A Uncertain significance (Jan 11, 2024)1918261
6-31863662-C-G Uncertain significance (Jul 26, 2022)1909535
6-31863701-T-C not specified Conflicting classifications of pathogenicity (Oct 23, 2023)2212653
6-31864537-G-A Benign (May 25, 2021)1226387
6-31864579-CA-C Benign (May 15, 2021)1243584
6-31864579-C-CA Benign (May 16, 2021)1269949
6-31864641-G-T Likely benign (Jan 02, 2024)1629239
6-31864642-T-C Likely benign (Oct 25, 2023)3023766
6-31864668-C-T Likely benign (Mar 20, 2023)2967561
6-31864677-A-G Likely benign (Nov 01, 2022)1659029
6-31864681-A-G not specified Uncertain significance (Dec 07, 2023)2198170
6-31864685-C-T Uncertain significance (Aug 27, 2023)3021460
6-31864686-G-A Likely benign (Apr 20, 2023)2729776
6-31864691-C-T Uncertain significance (May 15, 2022)1402384
6-31864703-C-T Uncertain significance (May 29, 2022)2190266
6-31864746-A-G Uncertain significance (Dec 25, 2023)2786081
6-31864752-C-T Uncertain significance (Sep 02, 2021)1512802
6-31864753-G-A Likely benign (Oct 04, 2023)2968046
6-31864803-G-C Likely benign (Aug 07, 2023)1617442
6-31864811-C-A Likely benign (Oct 17, 2023)1596993
6-31864837-G-A Likely benign (Jul 19, 2023)2787877
6-31864874-G-A not specified Uncertain significance (Jan 20, 2023)2191094
6-31864876-G-A Likely benign (May 20, 2023)2969149
6-31864881-G-A Uncertain significance (Jul 31, 2022)2147756
6-31864889-A-G not specified Uncertain significance (Nov 07, 2022)2322814

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
SLC44A4protein_codingprotein_codingENST00000229729 2115855
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.00e-140.87112548302651257480.00105
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.113444070.8450.00002354559
Missense in Polyphen123164.720.746731861
Synonymous1.571451710.8470.00001061419
Loss of Function2.052943.60.6650.00000234453

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.004940.00468
Ashkenazi Jewish0.000.00
East Asian0.0003280.000326
Finnish0.0005590.000554
European (Non-Finnish)0.0008630.000844
Middle Eastern0.0003280.000326
South Asian0.001490.00144
Other0.002130.00212

dbNSFP

Source: dbNSFP

Function
FUNCTION: Choline transporter that plays a role in the choline- acetylcholine system and is required to the efferent innervation of hair cells in the olivocochlear bundle for the maintenance of physiological function of outer hair cells and the protection of hair cells from acoustic injury (By similarity) (PubMed:23651124, PubMed:28013291). Also described as a thiamine pyrophosphate transporter in colon, may mediate the absorption of microbiota- generated thiamine pyrophosphate and contribute to host thiamine (vitamin B1) homeostasis (PubMed:24379411). {ECO:0000250|UniProtKB:Q7T2B0, ECO:0000269|PubMed:23651124, ECO:0000269|PubMed:24379411, ECO:0000269|PubMed:28013291}.;
Disease
DISEASE: Note=An interstitial deletion causing the fusion of exon 10 of CTL4 with the 3'-UTR of NEU has been detected in two patients affected by sialidosis.; DISEASE: Deafness, autosomal dominant, 72 (DFNA72) [MIM:617606]: A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. DFNA72 primarily affects the middle frequencies. It gradually progresses to whole-frequency hearing loss. {ECO:0000269|PubMed:28013291}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Choline metabolism in cancer - Homo sapiens (human);Metabolism of lipids;Amine compound SLC transporters;Metabolism;Transport of bile salts and organic acids, metal ions and amine compounds;Synthesis of PC;SLC-mediated transmembrane transport;Transport of small molecules;Glycerophospholipid biosynthesis;Phospholipid metabolism (Consensus)

Intolerance Scores

loftool
0.992
rvis_EVS
1.09
rvis_percentile_EVS
91.9

Haploinsufficiency Scores

pHI
0.394
hipred
N
hipred_score
0.372
ghis
0.408

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.101

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Slc44a4
Phenotype

Zebrafish Information Network

Gene name
slc44a4
Affected structure
neuromast hair cell
Phenotype tag
abnormal
Phenotype quality
decreased amount

Gene ontology

Biological process
phosphatidylcholine biosynthetic process;acetylcholine biosynthetic process;choline transport;positive regulation of cell growth;thiamine pyrophosphate transmembrane transport;otolith formation;neuromast hair cell development;transmembrane transport;acetylcholine secretion
Cellular component
plasma membrane;integral component of membrane;apical plasma membrane;extracellular exosome
Molecular function
choline transmembrane transporter activity;thiamine pyrophosphate transmembrane transporter activity